Background The life expectancy of the average American with diabetes has increased, but the quality of health and functioning during those extra years are unknown. We aimed to investigate the net eff ect of recent trends in diabetes incidence, disability, and mortality on the average age of disability onset and the number of healthy and disabled years lived by adults with and without diabetes in the USA. We assessed whether disability expanded or was compressed in the population with diabetes and compared the fi ndings with those for the population without diabetes in two consecutive US birth cohorts aged 50-70 years.
Introduction
Incidence and prevalence of both types of diabetes have more than doubled in the past 20 years in almost all demographic subgroups of the US population. 1 These trends have been accompanied by large reductions in mortality that have increased the number of years spent with diabetes for the average person and for the population overall. 2 As a result, the lifetime probability of diabetes has also increased substantially, and is now about 40% for both men and women in the USA. 3 Although yearly rates of several diabetes-related complications decreased during this period, 4 the eff ect of living more years of life with diabetes on the quality of those extra years of life remains unclear.
People with diabetes have double the incidence of physical disability, and the few estimates of trends in disability prevalence from surveys in the population with diabetes suggest that there has been no change in the past 20 years. 5 Thus, whether recent clinical and public health eff orts have been successful in compressing disability (ie, reducing the number of years with disability) while increasing lifespans remains unclear. Compression of disability occurs if the delay in onset of disability is greater than the increase in life expectancy. As a result, the average time spent in an active state (ie, disability free) will increase, both in absolute terms and as a proportion of total life expectancy. 6 Alternatively, expansion of disability occurs if the gain in total life expectancy is associated with longer periods of disability, implying that medical advances have extended life for those suff ering from disabling diseases, without changing the age of disability onset or the number of healthy years of life. Because diabetes is one of the most common disorders associated with increasing rather than decreasing prevalence, we assessed whether disability expanded or was compressed in the population with diabetes and compared the fi ndings with those for the population without diabetes in two consecutive US birth cohorts aged 50-70 years.
Methods
We analysed data from the Health and Retirement Study (HRS), a population-based, prospective health interview survey of a cohort of adults aged 50 years and older in the USA. 7, 8 These survey data were collected every 2 years from 1992 to 2012. We used birth cohorts to assess the net eff ect of recent trends in diabetes incidence, disability, and mortality. The fi rst cohort (cohort 1) included 9754 respondents (8687 without diabetes and 1067 with diabetes) born between 1931 and 1941 and surveyed in 1992 (baseline) and every 2 years until 2002. The second cohort (cohort 2) included 3027 respondents (2727 without diabetes and 300 with diabetes) born between 1942 and 1947 and surveyed in 2002 (baseline) and every 2 years up to 2012. Baseline response rates during the study ranged from 70% for cohort 2 to 81% for cohort 1, and the followup response rates ranged from 84% to 89% for cohort 1 and from 87% to 91% for cohort 2. 9 The HRS is sponsored by the National Institute on Aging and conducted by the Institute for Social Research at the University of Michigan. The health sciences institutional review board at the University of Michigan approved the HRS study design.
We developed a simulation model that incorporated the national levels of diabetes prevalence, incidence, and mortality in the two birth cohorts. Using the model, we calculated the average age of disability onset, disabilityfree years and disabled years, and life-years lost (ie, decrease in total remaining life-years up to age 70 years) between the ages of 50 and 70 years in the diabetes and non-diabetes populations in the two birth cohorts. To test the null hypothesis of no compression or expansion of disability, we compared cohort 1 (weighted to the 1992 US population of the birth cohort born during 1931-41, followed up until 2002) with cohort 2 (weighted to the 2002 US population of the birth cohort born during 1942-47, followed up until 2012).
Diabetes was defi ned as the self-report by a respondent to HRS of a diabetes diagnosis (ie, being told by a doctor that he or she has diabetes or high blood sugar) at fi rst interview or during the study period. 9 Disability was defi ned using three diff erent disability domains: mobility, instrumental activities of daily living, and activities of daily living. Mobility disability was based on responses to questions about diffi culty walking one block; walking several blocks; climbing one fl ight of stairs; stooping, crouching, or kneeling; and pushing or pulling a large object. 10 We defi ned mobility loss as having diffi culty with four or fi ve of these tasks. In 1992, instrumental activities of daily living-related disability was defi ned as having diffi culty with at least one of the following: reading a map, using a calculator, and using a microwave. These are the activities that are assumed to have been used by Wallace and Herzog who developed the method. 11 From 1994 to 2012, instrumental activities of daily living-related disability was defi ned diff erently, as diffi culty with any of the following: using the telephone, taking medication, handling money, shopping, and preparing meals. Further
Research in context
Evidence before this study We searched PubMed and Google Scholar for studies published in English up to Oct 16, 2015 , using the search terms "compression of morbidity", "expansion of morbidity", and "diabetes". Mortality rates in people with diabetes and yearly rates of several diabetes-related complications are decreasing but the eff ect of living more years of life with diabetes on the quality of those extra years of life remains unclear. Although fi ndings from cross-sectional studies have shown that the disability prevalence in people with diabetes has not changed in the past 20 years, it is unknown if clinical and public health eff orts have been successful in compressing disability (ie, reducing the number of years of disability into the last years of life). Few studies have quantifi ed healthy and disabled life-years in adults with diabetes. A previous analysis of Health and Retirement Survey data found that people with diabetes become disabled 6-7 years earlier than people without diabetes.
Added value of this study
We are not aware of previous studies examining trends in healthy and disabled life-years from birth cohorts within a national sample. In this comparison of disability and mortality between US adults born in the 1940s versus the 1930s, individuals with diabetes are generally becoming disabled later and living more disability-free years by the age of 70 years. These improvements in health status (which suggest a compression of morbidity), aff ected adults both with and without diabetes, both sexes, and were seen across diff erent disability defi nitions.
Implications of all the available evidence
Available evidence related to compression of disability in adults with diabetes suggests that healthy lifestyles that help to maintain a healthy weight and lean-to-fat ratios are eff ective in reducing disability in adults with diabetes. Similarly, evidence-based approaches to prevent diabetes and cardiovascular disease through both lifestyle modifi cation and preventive care are also important for continued reduction in diabetes-related morbidity and disability.
explanation of how these variables were constructed has been published elsewhere. 7 Activities of daily living-related disability was defi ned as having diffi culty in performing at least one of the following tasks: walking across a room, getting in and out of bed, dressing, bathing, and eating.
Deaths were confi rmed from the National Death Index and the Social Security Death Index. To obtain data for the health condition of deceased respondents before their death, proxies for the respondents were interviewed. Next of kin were interviewed if a respondent had died, and if no next of kin were contactable, a friend was contacted. If the participant's fi nancial estate was not settled at the time of the exit interview, a post-exit interview at the next wave was conducted.
Statistical analysis
We compared baseline characteristics between cohort 1 and cohort 2, in respondents with diabetes and in those without diabetes, using χ² statistics with 95% CIs and a signifi cance cutoff value of less than 0·05. We did logistic regression using generalised estimating equations to obtain annual incidence of disability and mortality according to diabetes status by age group and also to determine the age-specifi c yearly probability of becoming disabled, dying, and remission to a non-disabled state among those who become disabled. Respondents who entered the study with prevalent disability were excluded from the incidence and remission estimates. We used inverse probability weighting to reduce bias related to missing data, whether it was due to loss of follow-up or non-reporting by the respondent in that wave or previous waves. 12 In this method, logistic regression is used to determine the predicted value of having complete data; weights are the inverse of the probability of having complete data. To obtain these estimates, data were modelled with Stata (version 13).
Markov model with a 20 year time horizon
We developed a discrete-time Markov simulation model with annual transition. The model was applied to two populations, one for those with diabetes and the other for those who remained diabetes free. The models predict disability-related outcomes from ages 50-70 years, using probability estimates of disability, mortality, and remission (fi gure). During each 1 year interval, individuals can move from and to one of the fi ve states: not disabled, short-term disability, not disabled but with previous disability, longterm disability, and death. Because of the high recovery rates recorded in the data, we created two bridge states of short-term disability and not being disabled but had disability history. Short-term disability is defi ned as being disabled for less than 1 year, by contrast with long-term disability defi ned as remaining disabled for more than 1 year. In the model, individuals with short-term disability revert to not being disabled, die, or continue to be disabled after 1 year of disability onset. Based on data from HRS, individuals can have several episodes of short-term disability over a lifetime.
To understand the eff ect of diabetes on 20 year disability outcomes, we estimated and compared outcomes with those of individuals of the same ages without diabetes who remained without diabetes until death. The CIs of the 20 year estimates were estimated from Monte Carlo simulation, with 10 000 random draws of age-specifi c and sex-specifi c estimates (5000 for each sex) from the underlying parametric distributions derived from HRS data.
Role of the funding source
This study was funded by the US Department of Health & Human Services and the US Centers for Disease Control and Prevention. The funder of the study was involved in the study design, data collection, data analysis, data interpretation, and writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
Cohort 1 included 9754 respondents, 1067 of whom had a diagnosis of diabetes, and 8687 of whom did not; cohort 2 included 3027 respondents, 300 of whom had a diabetes diagnosis and 2727 of whom did not. Ageadjusted diabetes prevalence did not diff er between respondents born in the 1940s and those born in the 1930s (9·9%, 95% CI 9·3-10·4 vs 9·2%, 8·1-10·4). However, BMI, educational attainment, and age each diff ered by cohort (table 1). In participants with and without diabetes, the baseline prevalence of history of stroke and self-reported high blood pressure increased signifi cantly between the fi rst and second cohorts (p<0·05). In participants without diabetes, the prevalence of current smokers declined signifi cantly from 27·2% (95% CI 25·8-28·7) to 21·2% (18·8-23·8).
The proportions of respondents with prevalent diffi culty with activities of daily living and mobility loss at baseline were signifi cantly higher in those with diabetes than in those without. However, the prevalence of mobility loss and diffi culty with activities of daily living decreased signifi cantly among those in cohort 2 compared with cohort 1, for participants with and without diabetes. Diff erences in diffi culty with instrumental activities of daily living are not reported at baseline because of the diff erences in measure ments in 1992 from the rest of the interview years. We noted some signifi cant diff erences between cohorts within both age groups (ie, 50-60 years and 61-70 years) for incidence of disability, recovery from disability, and mortality by disability status, although it varied by diabetes status (p<0·05; table 2). In cohort 2 compared with cohort 1, incidence of mobility loss, instrumental activities of daily living-related disability, and activities of daily living-related disability decreased in those aged 50-60 years and 61-70 years in participants with and without diabetes. Recovery from incident disability increased signifi cantly among both age groups for all disability types, with the exception of mobility loss among those with diabetes aged 50-60 years.
In men with diabetes aged 50-60 years, we noted a signifi cant decrease in life-years lost (ie, decrease in total remaining life-years up to age 70 years) between the two cohorts (-1·3 years, 95% CI -1·7 to -0·8; from 2·8 to 1·5 for men aged 50 years; and -0·3 years, -0·6 to 0·0; from 1·6 to 1·3 for men aged 60 years), with a delay in the age of onset of disability from age 60 years for all disability types and from age 50 years for mobility loss and activities of daily living-related disability (table 3; appendix). From age 60 years, men with diabetes in cohort 2 had later age of disability onset for all three disability types (0·9-1·4 years later in cohort 2), more disability-free years (0·9-1·4 years fewer), and fewer disabled years (diff erence of 0·7-1·1 years) than those in cohort 1.
Similar to men with diabetes, in cohort 2 compared with cohort 1, men without diabetes had a postponement of disability onset, along with equivalent increases in disability-free years of life and a reduction in years of disabled life from age 60 to age 70 years. Comparing cohort 2 with cohort 1, women with diabetes from age 50 years had signifi cantly fewer life-years lost (across disability types), a delay in onset of disability age for mobility loss and activities of daily living-related disability, and no signifi cant change in disabled years for any of the disability types. Women with diabetes from age 60 in cohort 2 had later age of disability onset for all three disability types (1·2-1·6 years later), more disability-free years (1·2-1·6 more years), and fewer 
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Non-Hispanic white
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High blood pressure
Data are % (95% CI) or mean (SD). p values are from statistical tests of diff erences between cohort 1 and 2, in participants with diabetes and in those without diabetes.
Table 1: Baseline characteristics
See Online for appendix disabled years (1·1-1·4 fewer years) than those in cohort 1 (table 4) . We noted similarly encouraging fi ndings in women without diabetes, who also had signifi cant increases in non-disabled years and decreases in disabled years.
All diff erences between those with diabetes and without diabetes within each cohort by sex, age, and disability type were signifi cantly diff erent (p<0·0001).
Discussion
In this comparison of disability and mortality between US adults born in the 1940s versus the 1930s, people with diabetes are generally becoming disabled later and living more disability-free years by age 70 years. These improvements in health status, which suggest a compression of morbidity, aff ected adults both with and without diabetes, both sexes, and were seen across diff erent disability defi nitions. We noted some diff erences by sex-men had a decrease in life-years lost from ages 50 and 60 years,, whereas women only had a decrease in life-years lost from age 50 years.
The diff erence in healthy years over time was driven by three factors in our model: mortality, incident disability, and remission from disability. With the exception of disability defi ned by instrumental activities of daily livings, disability-free life-years increased in all groups because mortality risk and disability risk decreased simultaneously, along with an increase in remission from disability. However, the population without diabetes in the fi rst cohort had a greater number of healthy years and later disability onset than the population with diabetes. Even though they had less scope for improvement than those with diabetes, those without diabetes in cohort 2 improved signifi cantly compared with cohort 1 in terms of life-years lost for all disability types and disability-free years for all disability types (with 
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Data are estimates of the annual incidence per 100 person-years, adjusted for sex (95% CI), unless otherwise indicated. p values are for comparison between cohort 1 and cohort 2, within age group and disability metric. Estimates are the annual incidence per 100 person-years, adjusted for sex. the exception of instrumental activities of daily livingrelated disability from age 50 years) for men and women. Although our analyses could not assess the factors that might account for the compression of disability in the US population with diabetes, our fi ndings are consistent with the concurrent improvements in the management and control of cardiovascular disease risk factors and glycaemic control, as well as improved processes of care and reductions in diabetes-related complications and other chronic disorders, such as cardiovascular disease. [13] [14] [15] Decreases in mortality in people with diabetes has been reported previously in the USA 2 and elsewhere, 16 but such decreases can sometimes have the eff ect of supressing reductions in the prevalence of chronic diseases, as was shown by the increase rather than decrease in prevalence of stroke and heart disease over time in the population with diabetes.
According to fi ndings reported by Martin and colleagues, 17 from 1997 to 2007, diabetes increasingly contributed to disability in people aged 50-64 years. However, that study assessed the prevalence of disability, unlike our study, which excluded prevalent disability cases and assessed incidence of disability and remission from disability, which are diff erent metrics. Other reported causes of diffi culty with a physical function included depression, heart problems, hypertension, and weight problems. Although our analyses did not assess factors modifying the changes in disability, morbidity, and healthy life-years, our analysis of baseline characteristics suggests that increases in BMI, prevalent hypertension, and history of stroke are all plausible factors for the gap between those with diabetes and those without. Compared with non-diabetic adults, in adults with diabetes, class II and class III obesity increased more between the two cohorts; these categories of obesity 
Instrumental activities of daily living-related disability
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Data are n (95% CI). Table 3 : Estimated healthy and disabled years in US men with and without diabetes, from baseline age to 70 years carry, respectively, 1·4 and 1·8 times the prevalence of disability compared with normal weight people older than 65 years. 18 Stroke prevalence, which increased 4·7 percentage points over time in the population with diabetes, has been associated with a 50% increased risk of disability. 19 Although rates of diabetes-related complications have fallen substantially in the past two decades, the absolute numbers of adults with diabetes who have complications persists because of the continued increase in the prevalence of diabetes. 4 Our fi ndings show that in people with diabetes, by age 70 years, an increase in years of total life remaining combined with postponement or recovery from disability results in a greater number of healthy life-years in the later birth cohort. This fi nding could be related to increases in the number of people following a healthy lifestyle, which prolongs life expectancy and postpones disability. 6 However, the increase in healthy life-years might have been due to increased health-care utilisation, and in some cases, expensive procedures. For example, from 1999 to 2008, the rate of knee replacements increased substantially (tripling for people aged 45-64 years and doubling for those ≥65 years) in the USA, which substantially reduces pain and improves functioning in people with severe knee problems. 20 Future studies should focus on how other components of health care, whether effi cient, low-expense primary care, or advanced treatments for other chronic disorders such as cardiovascular diseases, cancers, and musculoskeletal disorders, are aff ecting disability rates. Our study has several limitations. First, our discretetime Markov model assumed that participants without diabetes would remain diabetes free until death. However, the age-specifi c probabilities used as input into the model included incident cases of diabetes. By using 1 year transition cycle simulations, the age-specifi c 
Instrumental activities of daily living-related disability 50 years
Data are n (95% CI). Table 4 : Estimated healthy and disabled years among US women with and without diabetes, from baseline age to 70 years probabilities by diabetes accounted for the incident diabetes cases (ie, those who were not disabled before diabetes diagnosis, because those who were previously disabled would have been censored after disability onset). Second, our Markov model does not allow for stratifi cation of the transitions by multiple factors, such as obesity, physical activity, high blood pressure, cardiovascular disease, education, and depression, which could account for many of the reported diff erences between populations with and without diabetes. Findings of a separate study of HRS data showed that lower wealth and education were associated with higher levels of disability and earlier onset of disability. 21 Thus, the greater educational attainment achieved in cohort 2 might be associated with the compression of disability and later onset of disability. Third, our study was limited by an absence of data beyond age 70 years in cohort 2, which led us to restrict analyses of both cohorts to the 50-70 years age range to permit a valid comparison of the two cohorts. Thus, our analyses should be regarded as examination of fairly early disability, as opposed to more common age-related disability that occurs between age 70 years and death. Fourth, data for age at diabetes diagnosis were not available for cohort 2 at baseline. Because cohort 2 was on average 1 year older than cohort 1 and the prevalence of obesity was greater in cohort 2, patients in cohort 2 probably had a longer duration of diabetes, which might have aff ected the onset of disability. Fifth, disability measures were self-reported diffi culty with performing tasks, which might not be regarded as a strict defi nition of disability, but we used four or fi ve tasks to defi ne severe mobility loss to lessen potential bias. Although our measurement of instrumental activities of daily living diff ered at baseline for cohort 1, there was consistency across the remaining interview years; therefore, this diff erence should pose minimum bias in assessing incidence and remission of instrumental activities of daily living-related disability. Finally, our study design does not allow the eff ects of period diff erences to be separated from cohort diff erences; there could be changes attributable to the year or period (eg, changes in technology that would lessen disability or changes in the environment that might aff ect disability) but we could not tease out factors from actual cohort diff erences. However, to our knowledge, our study is the fi rst to quantify whether later cohorts with diabetes experience a compression of morbidity relative to earlier cohorts.
Few studies have quantifi ed healthy and disabled lifeyears in adults with diabetes. [22] [23] [24] Results of a previous analysis of HRS data showed that people with diabetes become disabled 6-7 years earlier than people without diabetes. Estimates from the 2013 Global Burden of Disease Study (GBD) suggest that diabetes is the seventh leading cause of increased years with disability. 24 However, the GBD estimate of disabled lifeyears is based on a combination of prevalence and standard disability weights, which is driven by prevalence and therefore does not lend itself to direct comparison with our estimates, which incorporated individual-level disability incidence estimates that are independent of prevalence. Our analyses are also not directly comparable with studies of trends in disability prevalence because our estimates incorporate incidence of and remission from disability, as well as mortality. 17 We are not aware of previous studies examining trends in healthy and disabled life-years from birth cohorts within a national sample. In addition to having important implications for patients with diabetes and the families and health systems that care for them, trends in healthy years of life serve as an indication of whether clinical and public health goals to compress disability are being achieved. It is unknown whether the compression of disability among people with and without diabetes will continue. Our analyses only included people born up to 1947; investigators of one study examining the so-called baby boomer generation (ie, people born between 1947 and 1964) noted that diffi culty with activities of daily living increased signifi cantly for this generation. 25 If reduction in mortality occurs because of longer survival with diabetes and disability, then length of life with both will increase. Findings from one intervention study in obese adults with type 2 diabetes showed that a mean weight loss of 7% or more and increasing duration of physical activity to more than 175 min per week led to a reduction of 48% in the severity of mobility-related disability. 10 Additionally, in a systematic review on interventions to prevent disability in frail communitydwelling adults, 26 Daniels and colleagues reported that relatively long-lasting and multi-component, severaltimes-weekly physical activity programmes for moderately physically frail older people can be protective against disability. 26 Healthy lifestyle programmes including physical activity also reduce the risk of developing clinically signifi cant symptoms of depression and preserve physical quality of life in overweight adults with diabetes. 27 Because of the possible burden of new cases of mobility loss in people with and without diabetes aged 50-64 years, physical activity programmes might be helpful in reducing the risk of disability in this age group. Additionally, factors leading to disability, such as weight and physical and mental functioning, might be addressed so that the benefi ts of better health care are optimised. Ultimately, the decrease in disability onset due to primary prevention of diabetes might play an important part in achieving longer disability-free lifeyears.
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